Get the Stockscreener App
204.99
0.65%
-1.5223
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $204.99, with a volume of 828.52K.
It is down -0.65% in the last 24 hours and down -0.10% over the past month.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.
See More
Previous Close:
$206.51
Open:
$206.76
24h Volume:
828.52K
Relative Volume:
0.38
Market Cap:
$58.39B
Revenue:
$21.84B
Net Income/Loss:
$1.68B
P/E Ratio:
35.17
EPS:
5.8293
Net Cash Flow:
$2.67B
1W Performance:
+0.83%
1M Performance:
-0.10%
6M Performance:
+19.00%
1Y Performance:
-9.70%
1-Day Range:
$204.91
$208.34
1-Week Range:
$201.19
$213.08
52-Week Range:
$162.29
$235.34
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, MDLN, RMD, ALC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
204.95 | 58.84B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ISRG
Intuitive Surgical Inc
|
488.50 | 169.16B | 10.06B | 2.88B | 2.49B | 7.876 |
|
MDLN
Medline Inc
|
47.27 | 38.45B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
269.57 | 38.90B | 5.40B | 1.49B | 1.78B | 10.12 |
|
ALC
Alcon Inc
|
78.08 | 38.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-03-26 | Resumed | Citigroup | Buy |
| Sep-25-25 | Initiated | RBC Capital Mkts | Sector Perform |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| May-02-25 | Downgrade | Goldman | Buy → Neutral |
| May-02-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-02-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-01-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-01-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-22 | Resumed | Raymond James | Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-01-20 | Resumed | Goldman | Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
| May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-07-18 | Initiated | Deutsche Bank | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-18 | Resumed | BofA/Merrill | Buy |
| Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
| Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
A Look at Becton, Dickinson's Upcoming Earnings Report - Benzinga
How To Earn $500 A Month From Becton Dickinson Stock Ahead Of Q1 Earnings - Benzinga
3 Best Dividend Kings for 2026 - Investing.com
Piper Sandler Highlights Upcoming Segment Transition at Becton Dickinson (BDX) - Finviz
Becton, Dickinson and Company (NYSE:BDX) Now Covered by Citigroup - MarketBeat
OTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - GlobeNewswire Inc.
Strengthening Families & Communities LLC Buys 13,086 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Citi Upgrades Becton Dickinson & Co(BDX.US) to Buy Rating, Raises Target Price to $233 - 富途牛牛
Becton, Dickinson and Company (BDX): A Bull Case Theory - Finviz
Becton, Dickinson and Company (BDX) Stock Analysis: Navigating Growth in the Medical Instruments Sector - DirectorsTalk Interviews
Mirae Asset Global Investments Co. Ltd. Boosts Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson (NYSE:BDX) Will Pay A Dividend Of $1.05 - simplywall.st
Becton Dickinson's (NYSE:BDX) Dividend Will Be $1.05 - Yahoo Finance UK
Becton, Dickinson and Company $BDX Shares Acquired by TD Waterhouse Canada Inc. - MarketBeat
Becton, Dickinson and Company (BDX) Announces Executive Severanc - GuruFocus
Everett Harris & Co. CA Sells 7,344 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson Reshapes Portfolio With Waters Deal And Recycling Progress - Yahoo Finance UK
Becton Dickinson director Scott Bertram sells $159,593 in stock - MSN
Does The Recent Share Price Slide Make Becton Dickinson (BDX) Look Interesting Again? - simplywall.st
BD and Envetec Demonstrate Closed-Loop Recycling Solution for Laboratory Plastics in Health Care - Finviz
Recycling possible for PS petri dishes, other lab equipment - Plastics News
Becton Dickinson Hit With Lawsuit Over Catheter-Insertion Patent - Bloomberg Law News
The Analyst Verdict: Becton Dickinson In The Eyes Of 7 Experts - Benzinga
Becton, Dickinson and Company (NYSE:BDX) EVP Sells $15,204.75 in Stock - MarketBeat
Feld Michael, evp at Becton Dickinson, sells $15k in stock By Investing.com - Investing.com Australia
BD, Waters set completion date for $17.5B biosciences and diagnostics merger - MedTech Dive
Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
Feld Michael, evp at Becton Dickinson, sells $15k in stock - Investing.com India
Becton, Dickinson and Company $BDX Shares Sold by Y Intercept Hong Kong Ltd - MarketBeat
Piper Sandler Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $205 - 富途牛牛
How Investors Are Reacting To Becton Dickinson (BDX) Dividend Hike, Buyback Plan And AI-Driven Upgrades - simplywall.st
Becton Dickinson & Co To Go Ex-Dividend On March 10th, 2026 With 1.05 USD Dividend Per Share - 富途牛牛
BECTON, DICKINSON Q1 2026 Earnings Preview: Recent $BDX Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
$17.5B BD Spinoff Nears Completion - Medical Device and Diagnostic industry
BD Biosciences & Diagnostic Solutions Spin-Off to Combine With Waters in Reverse Morris Trust - citybiz
BD sets date for spin-off of Biosciences & Diagnostics Solutions business to Waters - MassDevice
Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business - Financial Times
(01/27/26) Top Picks 2026: Becton, Dickinson & Co. (BDX) - moneyshow.com
Becton, Dickinson and Company $BDX Holdings Lifted by Sector Gamma AS - MarketBeat
Becton, Dickinson and Company $BDX Shares Purchased by Commerzbank Aktiengesellschaft FI - MarketBeat
BDX and WST Stocks Fall Amid Novo Nordisk's Oral Wegovy Success - GuruFocus
BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation - Finviz
Becton, Dickinson and Co (NYSE:BDX) Shows High Technical and Setup Ratings for Potential Breakout - Chartmill
BICO company Biosero launches GoSimple™, a standardized automation-ready workcell with selected instruments from Sartorius and Becton, Dickinson and Company (BD) - marketscreener.com
BD and Ypsomed Expand Partnership to Target Growing Biologics Market - Yahoo Finance
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $210 - 富途资讯
Universal Beteiligungs und Servicegesellschaft mbH Acquires 8,561 Shares of Becton, Dickinson and Company $BDX - MarketBeat
BD and Ypsomed partner to develop 5.5 mL prefillable syringe By Investing.com - Investing.com Nigeria
BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market - Finviz
BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy System - Yahoo Finance
BD and Ypsomed partner to develop 5.5 mL prefillable syringe - Investing.com
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.44%
0.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):